These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1892634)

  • 41. Neuromodulation of experimental Shigella infection reduces damage to the gut mucosa.
    Svensson L; Bergquist J; Wennerås C
    Microbes Infect; 2004 Mar; 6(3):256-64. PubMed ID: 15026012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles for T and NK cells in the innate immune response to Shigella flexneri.
    Le-Barillec K; Magalhaes JG; Corcuff E; Thuizat A; Sansonetti PJ; Phalipon A; Di Santo JP
    J Immunol; 2005 Aug; 175(3):1735-40. PubMed ID: 16034114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Membrane component of Shigella flexneri and their relationship to bacteria antigenicity and virulence].
    Jin L; Su X
    Wei Sheng Wu Xue Bao; 1990 Feb; 30(1):48-53. PubMed ID: 2188429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a new guinea-pig model of shigellosis.
    Barman S; Saha DR; Ramamurthy T; Koley H
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):304-14. PubMed ID: 21539623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
    Van De Verg LL; Bendiuk NO; Kotloff K; Marsh MM; Ruckert JL; Puryear JL; Taylor DN; Hartman AB
    Vaccine; 1996 Aug; 14(11):1062-8. PubMed ID: 8879103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis.
    Singer M; Sansonetti PJ
    J Immunol; 2004 Sep; 173(6):4197-206. PubMed ID: 15356171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens.
    Gemski P; Sheahan DG; Washington O; Formal SB
    Infect Immun; 1972 Aug; 6(2):104-11. PubMed ID: 4569915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The epithelial proliferative activity of the mucosa of the large intestine in dysentery patients at the acute period of the disease depending on the expression of morphological changes].
    Borovskaia TF; Timoshin SS; Shalygina NB
    Arkh Patol; 1994; 56(5):48-50. PubMed ID: 7695494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies.
    Rout WR; Formal SB; Giannella RA; Dammin GJ
    Gastroenterology; 1975 Feb; 68(2):270-8. PubMed ID: 1090480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.
    FORMAL SB; LABREC EH; KENT TH; FALKOW S
    J Bacteriol; 1965 May; 89(5):1374-82. PubMed ID: 14293011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.
    Oaks EV; Hale TL; Formal SB
    Infect Immun; 1986 Jul; 53(1):57-63. PubMed ID: 3721580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular and cellular biology of Shigella flexneri invasiveness: from cell assay systems to shigellosis.
    Sansonetti PJ
    Curr Top Microbiol Immunol; 1992; 180():1-19. PubMed ID: 1505204
    [No Abstract]   [Full Text] [Related]  

  • 55. OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis.
    Sansonetti PJ; Arondel J; Fontaine A; d'Hauteville H; Bernardini ML
    Vaccine; 1991 Jun; 9(6):416-22. PubMed ID: 1887672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular and Cellular Mechanisms of Shigella flexneri Dissemination.
    Agaisse H
    Front Cell Infect Microbiol; 2016; 6():29. PubMed ID: 27014639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
    Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
    Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis.
    Perdomo OJ; Cavaillon JM; Huerre M; Ohayon H; Gounon P; Sansonetti PJ
    J Exp Med; 1994 Oct; 180(4):1307-19. PubMed ID: 7931064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
    Kotloff KL; Winickoff JP; Ivanoff B; Clemens JD; Swerdlow DL; Sansonetti PJ; Adak GK; Levine MM
    Bull World Health Organ; 1999; 77(8):651-66. PubMed ID: 10516787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis.
    Islam D; Veress B; Bardhan PK; Lindberg AA; Christensson B
    Infect Immun; 1997 Feb; 65(2):739-49. PubMed ID: 9009337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.